STREAMLINE HEALTH SOLUTIONS INC.: 10-Q filed 2016-12-07
What STREAMLINE HEALTH SOLUTIONS INC. reported in its quarterly report filed 2016-12-07 (fiscal Q3 2016): 35 published measures, 98 facts as tagged in accession 0001628280-16-021866.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-12-07
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001628280-16-021866 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STREAMLINE HEALTH SOLUTIONS INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 40,148,530 | USD | |
| At 2016-01-31 | 50,146,018 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 18,896,669 | USD | |
| At 2016-01-31 | 26,147,840 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 12,401,876 | USD | |
| At 2016-01-31 | 16,024,128 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 2,540,462 | USD | |
| At 2016-01-31 | 9,882,136 | USD | |
| At 2015-10-31 | 8,505,736 | USD | |
| At 2015-01-31 | 6,522,600 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -1,930,472 | USD | 92 |
| 2016-02-01 to 2016-10-31 | -4,142,381 | USD | 274 |
| 2015-08-01 to 2015-10-31 | -456,661 | USD | 92 |
| 2015-02-01 to 2015-10-31 | -2,886,873 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | -1,243,419 | USD | 274 |
| 2015-02-01 to 2015-10-31 | 3,953,930 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | 501,148 | USD | 274 |
| 2015-02-01 to 2015-10-31 | 243,283 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | -2,776,429 | USD | 274 |
| 2015-02-01 to 2015-10-31 | -1,727,511 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | -3,321,826 | USD | 274 |
| 2015-02-01 to 2015-10-31 | -243,283 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | -68,006,666 | USD | |
| At 2016-01-31 | -63,864,285 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 19,645,521 | shares | 92 |
| 2016-02-01 to 2016-10-31 | 19,477,538 | shares | 274 |
| 2015-08-01 to 2015-10-31 | 18,746,632 | shares | 92 |
| 2015-02-01 to 2015-10-31 | 18,658,626 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 19,645,521 | shares | 92 |
| 2016-02-01 to 2016-10-31 | 19,477,538 | shares | 274 |
| 2015-08-01 to 2015-10-31 | 18,746,632 | shares | 92 |
| 2015-02-01 to 2015-10-31 | 18,658,626 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -0.1 | USD/shares | 92 |
| 2016-02-01 to 2016-10-31 | -0.26 | USD/shares | 274 |
| 2015-08-01 to 2015-10-31 | -0.04 | USD/shares | 92 |
| 2015-02-01 to 2015-10-31 | -0.21 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -0.1 | USD/shares | 92 |
| 2016-02-01 to 2016-10-31 | -0.26 | USD/shares | 274 |
| 2015-08-01 to 2015-10-31 | -0.04 | USD/shares | 92 |
| 2015-02-01 to 2015-10-31 | -0.21 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 1,702 | USD | 92 |
| 2016-02-01 to 2016-10-31 | 5,104 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 3,113 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 2,645 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 2,103,136 | USD | |
| At 2016-01-31 | 2,454,075 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 433,000 | USD | 92 |
| 2016-02-01 to 2016-10-31 | 1,342,513 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 575,000 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 1,858,588 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -1,769,344 | USD | 92 |
| 2016-02-01 to 2016-10-31 | -3,717,291 | USD | 274 |
| 2015-08-01 to 2015-10-31 | -357,645 | USD | 92 |
| 2015-02-01 to 2015-10-31 | -4,125,369 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 7,518,786 | USD | |
| At 2016-01-31 | 16,203,437 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 98,871 | USD | 92 |
| 2016-02-01 to 2016-10-31 | 380,897 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 206,286 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 698,402 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 9,968,933 | USD | |
| At 2016-01-31 | 14,114,383 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 1,089,276 | USD | |
| At 2016-01-31 | 1,136,779 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 16,184,667 | USD | |
| At 2016-01-31 | 16,184,667 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 2,956,880 | USD | |
| At 2016-01-31 | 4,199,315 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 3,212,350 | USD | 92 |
| 2016-02-01 to 2016-10-31 | 10,153,140 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 2,351,082 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 10,636,370 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | 1,969,415 | USD | 92 |
| 2016-02-01 to 2016-10-31 | 5,800,169 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 2,258,092 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 6,715,641 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 19,684,284 | shares | |
| At 2016-01-31 | 18,783,540 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 5,369,298 | USD | |
| At 2016-01-31 | 4,861,821 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 3,266,162 | USD | |
| At 2016-01-31 | 2,407,746 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-10-31 | 7,726,910 | USD | |
| At 2016-01-31 | 8,155,325 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -2,003,182 | USD | 92 |
| 2016-02-01 to 2016-10-31 | -5,018,316 | USD | 274 |
| 2015-08-01 to 2015-10-31 | -803,000 | USD | 92 |
| 2015-02-01 to 2015-10-31 | -3,853,887 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | 895,438 | USD | 274 |
| 2015-02-01 to 2015-10-31 | 930,508 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | 976,338 | USD | 274 |
| 2015-02-01 to 2015-10-31 | 1,011,690 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2016-10-31 | -60,555 | USD | 92 |
| 2016-02-01 to 2016-10-31 | -39,089 | USD | 274 |
| 2015-08-01 to 2015-10-31 | 110,383 | USD | 92 |
| 2015-02-01 to 2015-10-31 | 1,939,543 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-02-01 to 2016-10-31 | -78,320 | USD | 274 |
| 2015-02-01 to 2015-10-31 | -1,505,462 | USD | 273 |
Inspect the source
- Entity
- STREAMLINE HEALTH SOLUTIONS INC. / CIK 0001008586
- Captured
- SEC response SHA-256
f28ec2b62f459f9e1502e7518fb1b41cf9eab0c85e2282d838d54aa5e44579c9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001008586.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))